Elsevier

Ophthalmology

Volume 111, Issue 2, February 2004, Pages 259-264
Ophthalmology

Original article
Variable corneal compensation improves discrimination between normal and glaucomatous eyes with the scanning laser polarimeter

https://doi.org/10.1016/j.ophtha.2003.05.015Get rights and content

Abstract

Purpose

The presently available scanning laser polarimeter (SLP) has a fixed corneal compensator (FCC) that neutralizes corneal birefringence only in eyes with birefringence that matches the population mode. A prototype variable corneal compensator (VCC) provides neutralization of individual corneal birefringence based on individual macular retardation patterns. The aim of this study was to evaluate the relative ability of the SLP with the FCC and with the VCC to discriminate between normal and glaucomatous eyes.

Design

Prospective, nonrandomized, comparative case series.

Participants

Algorithm-generating set consisting of 56 normal eyes and 55 glaucomatous eyes and an independent data set consisting of 83 normal eyes and 56 glaucomatous eyes.

Testing

Sixteen retardation measurements were obtained with the SLP with the FCC and the VCC from all subjects.

Main outcome measures

Dependency of parameters on age, gender, ethnic origin, and eye side was sought. Logistic regression was used to evaluate how well the various parameters could detect glaucoma. Discriminant functions were generated, and the area under the receiver operating characteristic (ROC) curve was determined.

Results

Discrimination between normal and glaucomatous eyes on the basis of single parameters was significantly better with the VCC than with the FCC for 6 retardation parameters: nasal average (P = 0.0003), superior maximum (P = 0.0003), ellipse average (P = 0.002), average thickness (P = 0.003), superior average (P = 0.010), and inferior average (P = 0.010). Discriminant analysis identified the optimal combination of parameters for the FCC and for the VCC. When the discriminant functions were applied to the independent data set, areas under the ROC curve were 0.84 for the FCC and 0.90 for the VCC (P<0.021). When the discriminant functions were applied to a subset of patients with early visual field loss, areas under the ROC curve were 0.82 for the FCC and 0.90 for the VCC (P<0.016).

Conclusion

Individual correction for corneal birefringence with the VCC significantly improved the ability of the SLP to distinguish between normal and glaucomatous eyes and enabled detection of patients with early glaucoma.

Section snippets

Materials and methods

Algorithms to discriminate between normal and glaucomatous eyes were generated from data derived from patients seen at 3 sites (Glaucoma Division, Jules Stein Eye Institute, Los Angeles; Glaucoma Research Unit, Moorfields Eye Hospital, London; and Bascom Palmer Eye Institute, Palm Beach Gardens, Florida). These algorithms were then tested on an independent data set derived from patients seen at a fourth site (Rotterdam Eye Hospital, Rotterdam, The Netherlands).

Algorithm-generating set

There were no statistically significant differences in gender, eye side, or ethnicity among the study groups, but the normal subjects were significantly younger than the patients with glaucoma. Regression analysis was performed on both FCC and VCC normal data to determine the effect of age on all GDx parameters. Several retardation parameters measured with the VCC had a significant correlation with age. These were ellipse average (P = 0.003), superior average (P = 0.008), inferior average (P =

Discussion

Scanning laser polarimetry provides reproducible, quantitative measurements of the peripapillary RNFL based on its birefringent properties.14, 15 Histologic validation of retardation measurements obtained with SLP has been reported in 2 studies. Weinreb and associates performed RNFL thickness measurements on 2 enucleated monkey eyes with the cornea and lens removed, and a good correlation was found between RNFL thickness and retardation.16 In the second study, with intact primate eyes, Morgan

Acknowledgements

The authors thank Nicholas Reus, PhD, of Rotterdam Eye Hospital; Harmohina Bagga, MD, of Bascom Palmer Eye Institute; and Ed White of Moorfields Eye Hospital for their invaluable assistance with data collection.

References (22)

  • Dreher A, Reiter K, inventors; Laser Diagnostic Technologies, Inc, assignee. Reitinal eye disease diagnostic system. US...
  • Cited by (55)

    • Imaging of the optic nerve and retinal nerve fiber layer: An essential part of glaucoma diagnosis and monitoring

      2014, Survey of Ophthalmology
      Citation Excerpt :

      GDx provides reproducible measurement of RNFL thickness.13,23,63,69 GDx VCC outperforms the earlier iterations of this technology that used fixed corneal compensation in its ability to discriminate between healthy and glaucomatous eyes.12,20,59,62 GDx ECC performs better than VCC in the detection of early glaucoma.36,56

    • Scanning laser polarimetry and confocal scanning laser ophthalmoscopy: technical notes on their use in glaucoma

      2008, Progress in Brain Research
      Citation Excerpt :

      This latest version of the RNFL analyzed is named GDx-VCC (variable corneal compensator), which compensates the individual corneal birefringence hence allowing a good correction of the corneal polarization effect. In this way, a more reliable evaluation of the RNFL thickness can be achieved (Weinreb et al., 2002b; Tannenbaum et al., 2004). Before performing the test, it is necessary to insert patients’ personal and clinical data, such as date of birth, gender, ethnicity, associated systemic disease, and spherical equivalent.

    • Diagnostic Accuracy of Scanning Laser Polarimetry with Enhanced versus Variable Corneal Compensation

      2007, Ophthalmology
      Citation Excerpt :

      Scanning laser polarimetry has evolved in recent years. Its successive generations have all been capable of differentiating between healthy and glaucomatous eyes.17–19,31–33 However, ABPs may occur in SLP images.

    View all citing articles on Scopus

    Manuscript no. 220879.

    Supported in part by National Institutes of Health grants R01EY12738 (JC) and R01-EY08684 (DSG).

    The authors have no financial interest in any device or technique described in this article. Drs Caprioli, Greenfield, and Lemij are members of the Clinical Advisory Board, Laser Diagnostic Technology, San Diego, California.

    View full text